RUA Life Sciences plc
RUA.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £1 | -£1,440 | -£2,003 | -£2,067 |
| Dep. & Amort. | £421 | £364 | £358 | £313 |
| Deferred Tax | £0 | £0 | £10 | -£88 |
| Stock-Based Comp. | £110 | -£35 | £102 | £145 |
| Change in WC | £182 | -£289 | £700 | -£458 |
| Other Non-Cash | -£933 | £72 | -£341 | -£206 |
| Operating Cash Flow | -£219 | -£1,328 | -£1,174 | -£2,361 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£62 | -£55 | -£449 | -£904 |
| Net Acquisitions | £102 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £30 | -£30 | £0 | £0 |
| Investing Cash Flow | £70 | -£85 | -£449 | -£904 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£196 | -£86 | £132 | -£66 |
| Stock Issued | £0 | £3,974 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | £0 | £0 | £0 |
| Financing Cash Flow | -£196 | £3,888 | £132 | -£66 |
| Forex Effect | -£19 | -£28 | £12 | £0 |
| Net Chg. in Cash | -£364 | £2,447 | -£1,479 | -£3,331 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £3,931 | £1,484 | £2,963 | £6,294 |
| End Cash | £3,567 | £3,931 | £1,484 | £2,963 |
| Free Cash Flow | -£281 | -£1,383 | -£1,623 | -£3,265 |